Author(s): Kamb A, Wee S, Lengauer C
Abstract Share this page
Abstract Thirty-five years after the 'war on cancer' was declared, the discovery of anticancer drugs remains a highly challenging endeavour. Here, we consider the factors responsible, such as tumour heterogeneity, and suggest strategies to improve the chances of short-term success in the development of novel anticancer drugs.
This article was published in Nat Rev Drug Discov
and referenced in Journal of Nanomedicine & Nanotechnology